Brett Wolfson-Stofko, Phd
AeroLeads people directory · profile

Brett Wolfson-Stofko, Phd Email & Phone Number

Manager of Harm Reduction & Health Services at Homes First at Homes First
Location: Greater Toronto Area, Canada 14 work roles 3 schools
1 work email found @homesfirst.on.ca LinkedIn matched
✓ Verified July 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email b****@homesfirst.on.ca
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Manager of Harm Reduction & Health Services at Homes First
Location
Greater Toronto Area, Canada
Company size

Who is Brett Wolfson-Stofko, Phd? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Brett Wolfson-Stofko, Phd is listed as Manager of Harm Reduction & Health Services at Homes First at Homes First, a with 114 employees, based in Greater Toronto Area, Canada. AeroLeads shows a work email signal at homesfirst.on.ca and a matched LinkedIn profile for Brett Wolfson-Stofko, Phd.

Brett Wolfson-Stofko, Phd previously worked as Manager of Harm Reduction and Health Services at Homes First and Manager of Harm Reduction at Homes First. Brett Wolfson-Stofko, Phd holds Doctor Of Philosophy (Ph.D.), Biomedical Sciences (Biochemistry) from Albert Einstein College Of Medicine.

Company email context

Email format at Homes First

This section adds company-level context without repeating Brett Wolfson-Stofko, Phd's masked contact details.

*@homesfirst.on.ca
71% confidence

AeroLeads found 1 current-domain work email signal for Brett Wolfson-Stofko, Phd. Compare company email patterns before reaching out.

Profile bio

About Brett Wolfson-Stofko, Phd

I received my bachelors degree in Neuroscience from the University of Delaware then worked at Johns Hopkins School of Medicine characterizing novel neurotherapetics to treat HIV-associated neurocognitive disorders (HAND).I then completed my PhD in Biochemistry at Albert Einstein College of Medicine characterizing enzymes from Mycobacterium tuberculosis and identifying potential drug targets.During graduate school, my professional focus shifted from basic science towards the design of public health & harm reduction programs in order to reduce the spread of disease and prevent drug overdose deaths.I then became a Project Coordinator working for BOOM!Health, a syringe exchange in the South Bronx, coordinating a clinical trial designed to determine the accuracy of a 3-in-1 rapid test for HIV/HCV/HBV.I was then awarded a Ruth L. Kirschstien National Service Award (T32) Postdoctoral Fellowship from National Institutes of Health (NIH) through National Development & Research Institutes/Center for Drug Use & HIV/HCV Research (CDUHR) at New York University Rory Meyers College of Nursing in the Behavioral Science Training (BST) in Drug Abuse Research Program. During this time I conducted quantitative, qualitative and ethnographic research on opioid overdose prevention and disease transmission. I also received a CDUHR pilot grant, as the Principal Investigator, focused on the design and implementation of an opioid overdose and needle stick prevention program designed specifically for business managers and staff who encounter opioid overdoses in their business. This work has been published in peer-reviewed scientific journals and been presented at both national and international conferences (a list of presentations is available upon request).Additionally, I've taught at John Jay College of Criminal Justice and consulted for New York Academy of Medicine and New York City Department of Health and Mental Hygiene. I've also published Op-Eds advocating for the expansion of harm reduction services.Upon re-locating to Toronto, I worked at Street Health's Overdose Prevention Site (OPS) supervising drug consumption and responding to overdoses. I then worked at VIRCAN to design and manage research studies focused on optimizing HCV and HBV screening and treatment strategies.I currently oversee harm reduction and health supports for people residing in Homes First's shelters, shelter-hotels, housing, and supportive housing sites across Toronto and provide harm reduction best practice guidance to Toronto Shelter & Support Services and Toronto Public Health.

Listed skills include Western Blotting, Biochemistry, Protein Chemistry, Cell Biology, and 27 others.

Current workplace

Brett Wolfson-Stofko, Phd's current company

Company context helps verify the profile and gives searchers a useful next step.

Homes First
Homes First
Manager of Harm Reduction & Health Services at Homes First
toronto, ontario, canada
Employees
114
AeroLeads page
14 roles

Brett Wolfson-Stofko, Phd work experience

A career timeline built from the work history available for this profile.

Manager Of Harm Reduction And Health Services

Current

Toronto, Ontario, Canada

Manage a team of supervisors and health navigators to optimize and expand harm reduction and health services in shelters, shelter-hotels, supportive housing and non-supportive housing programs with the goal of reducing overdose, the spread of disease, and streamlining resident access to primary and mental health care.

Sep 2023 - Present

Manager Of Harm Reduction

Toronto, Ontario, Canada

Optimizing harm reduction and health services to reduce overdose, the spread of disease, and streamline resident's access to primary and mental health care in shelters, shelter-hotels, and supportive housing programs.

Mar 2022 - Sep 2023

Affiliated Investigator, Center For Drug Use And Hiv/Hcv Research (Cduhr)

Current

New York, Ny

The mission of CDUHR is to end the HIV and HCV epidemics in drug using populations and their communities by conducting transdisciplinary research and disseminating its findings to inform programmatic, policy, and grass roots initiatives at the local, state, national and global levels.

Jul 2015 - Present

Postdoctoral Research Fellow

New York, Ny

My Ruth L. Kirschstein National Research Service Award (NIH T32) was transferred to the Center for Drug Use and HIV/HCV Research (CDUHR) at Rory Meyers College of Nursing at New York University. Here I continued my research on pubic injection risk environments and designing interventions capable of reducing overdose mortality and HIV/HCV transmission. My research focused on training business managers on how to recognize and reverse opioid overdoses using naloxone and to investigate community stakeholder and people who inject drugs perspectives on the operation of Supervised Injection Facilities (SIF) utilizing both quantitative and qualitative methods.

Jul 2016 - Jun 2017

Scientific Associate

Toronto, Canada Area

Viral Hepatitis Care Network (VIRCAN) is a structured academic-community partnership that will address issues throughout the care of viral hepatitis, from diagnosis to treatment to cure. I am currently managing two Phase 4 clinical trials to improve HCV screening, linkages to care, and evaluate a rapid diagnostic. Liaising with Cepheid to obtain Investigational Testing Authorization (ITA) from Health Canada. Writing and editing clinical study protocols, grants, abstracts, presentations, and publications. Developing media strategies to raise public health awareness about HCV and HBV testing and treatment options. Collaborating on a systematic review & meta-analysis of the diagnostic accuracy of point-of-care HCV RNA tests. Identifying and liaising with community partners to expand HCV and HBV screening. Conducting HCV rapid tests and dried blood spot collection at community screening events.

Jan 2020 - Mar 2022

Overdose Prevention Worker

Toronto, Canada Area

I supervised injections, responded to overdoses, and connected people to care at Street Health's Overdose Prevention Site (OPS). Street Health is a non-profit community based agency that strives to improve the health and well-being of homeless and under-housed people in downtown Toronto. We offer physical and mental health programs, as well as supports that improve clients’ ability to access other services. Our work is focused in the neighbourhood around Dundas and Sherbourne Streets, an area with the largest concentration of homeless shelters and drop-in centres in Canada. On an average day, 115 clients come through our doors; we have 60,500 client visits each year.Street Health opened an Overdose Prevention Site in June 2018 as a response to the increased level of overdoses in our neighbourhood, in our driveway, and among our clients. Sherbourne and Dundas has the second highest number of calls to 911 for overdose in the entire city.

Nov 2019 - Jan 2020

Research Scientist

New York, Ny

Evaluated my CDUHR pilot grant focused on the training of business staff and managers on how to reverse opioid overdoses with intranasal naloxone and how to prevent needle sticks in their place of business. Collaborated on and published a qualitative stakeholder analysis examining interactions between opioid-overdose survivors, first responders, and healthcare professionals that influence opioid risk behaviors post-overdose.

Jun 2017 - Jun 2019

Research Associate

New York, Ny

Coordinated a two-year longitudinal cohort study on overdose risks of 218 opioid-using US military veterans investigating opioid-related risk behaviors, social reintegration, and trauma which culminated into an overdose prevention and naloxone administration ‘train-the-trainer’ program for veterans. I conducted qualitative interviews, naloxone training, data analysis, manuscript preparation, and assisted in project management. I was also the Thesis Mentor for a Master of Public Health student at Icahn School of Medicine at Mount Sinai.

Jul 2015 - Jun 2017

Post-Doctoral Research Fellow

New York, Ny

Awarded a Ruth L. Kirschstein National Research Service Award Postdoctoral Fellowship in the Behavioral Sciences Training Program in Drug Abuse Research (NIH T32). My research primarily focused on opioid overdose occurring in business bathrooms. I was awarded a pilot grant from the Center for Drug Use and HIV/HCV Research (CDUHR) at New York University to: 1) design and evaluate an opioid overdose and needlestick prevention training specifically for businesses and 2) conduct a qualitative study on businesses perspectives on supervised injection facilities (SIF). Results from these projects led to an amendment to New York State's Good Samaritan law that now permits businesses to procure and administer naloxone to people suspected of overdosing on opioids and New York City Department of Health and Mental Hygiene is now training businesses on opioid overdose recognition and naloxone administration. This fellowship was transferred to NYU in 2016.

Jun 2015 - Jun 2016

Adjunct Professor

New York, Ny

Adjunct Professor in the Department of Anthropology teaching Drug Use and Abuse in American Society.

Jan 2017 - Jun 2017

Project Coordinator

226 E 144Th St, Bronx, Ny

Coordinated a Phase 2B clinical trial at a syringe exchange evaluating the accuracy of a HIV/HCV/HBV rapid test. Supervised a team of eight people consisting of social workers, phlebotomists, peers, and a research assistant. Monitored budget to ensure that supplies and incentives were properly distributed. Adhered to strict timelines for deliverables and reporting. Worked directly with people who inject drugs, people who are unstably housed, people who are HIV+/HCV+/HBV+, people who participate in survival sex, and the LGBTQ2S+ community.

Jul 2014 - Jun 2015

Doctoral Student

Bronx, Ny

Thesis research consisted of kinetically and mechanistically characterizing enzymes from Mycobacterium tuberculosis in order to identify potential drug targets using steady-state kinetics and isotope effects.

Aug 2009 - Jun 2014

Senior Research Technician

Baltimore, Maryland Area

Conducted neuropharmacological research on HIV-associated Cognitive Disorders (HAND). Identified the neuroprotective mechanism of paroxetine against oxidative stress produced by the HIV proteins Tat and gp120. Conducted pharmacokinetic and drug disposition studies. Trained five undergraduates on in vitro and in vivo laboratory techniques,.

Feb 2008 - Aug 2009

Research Student

Baltimore, Maryland, United States

Conducted in vivo neurotoxicology research on amphetamine-type stimulants (i.e. amphetamine, methamphetamine, methylenedioxymethamphetamine (MDMA)) in murine and non-human primate models.

Jun 2006 - Aug 2006
Team & coworkers

Colleagues at Homes First

Other employees you can reach at homesfirst.on.ca. View company contacts for 114 employees →

3 education records

Brett Wolfson-Stofko, Phd education

Doctor Of Philosophy (Ph.D.), Biomedical Sciences (Biochemistry)

Activities and Societies: Albert Einstein Social Medicine Course - Lead Organizer. Editor-In-Chief - Ad Libitum: Literary and Art.

FAQ

Frequently asked questions about Brett Wolfson-Stofko, Phd

Quick answers generated from the profile data available on this page.

What company does Brett Wolfson-Stofko, Phd work for?

Brett Wolfson-Stofko, Phd works for Homes First.

What is Brett Wolfson-Stofko, Phd's role at Homes First?

Brett Wolfson-Stofko, Phd is listed as Manager of Harm Reduction & Health Services at Homes First at Homes First.

What is Brett Wolfson-Stofko, Phd's email address?

AeroLeads has found 1 work email signal at @homesfirst.on.ca for Brett Wolfson-Stofko, Phd at Homes First.

Where is Brett Wolfson-Stofko, Phd based?

Brett Wolfson-Stofko, Phd is based in Greater Toronto Area, Canada while working with Homes First.

What companies has Brett Wolfson-Stofko, Phd worked for?

Brett Wolfson-Stofko, Phd has worked for Homes First, New York University, Vircan Care & Research Inc., Street Health Community Nursing Foundation, and National Development And Research Institutes, Inc. (Ndri).

Who are Brett Wolfson-Stofko, Phd's colleagues at Homes First?

Brett Wolfson-Stofko, Phd's colleagues at Homes First include Kate Hatoum, Julie J., Susan Sun, Amazing Carol, and Edgar Asaasira.

How can I contact Brett Wolfson-Stofko, Phd?

You can use AeroLeads to view verified contact signals for Brett Wolfson-Stofko, Phd at Homes First, including work email, phone, and LinkedIn data when available.

What schools did Brett Wolfson-Stofko, Phd attend?

Brett Wolfson-Stofko, Phd holds Doctor Of Philosophy (Ph.D.), Biomedical Sciences (Biochemistry) from Albert Einstein College Of Medicine.

What skills is Brett Wolfson-Stofko, Phd known for?

Brett Wolfson-Stofko, Phd is listed with skills including Western Blotting, Biochemistry, Protein Chemistry, Cell Biology, Cell Culture, Molecular Cloning, Fluorescence Microscopy, and Immunohistochemistry.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.